Browsing Tag
EAACI Congress
1 post
Is Dupixent now the gold standard for asthma with nasal polyps? Inside Sanofi and Regeneron’s big study win
Dupixent outperforms Xolair in phase 4 respiratory trial for chronic rhinosinusitis with asthma. Find out what this means for Sanofi and Regeneron’s growth.